Cargando…
Obesity, Insulin Resistance and Cancer Risk
Obesity is a known cause of metabolic syndrome which includes Type II diabetes, hypertension, and dyslipidemia. It is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension....
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815827/ https://www.ncbi.nlm.nih.gov/pubmed/16127767 http://dx.doi.org/10.3349/ymj.2005.46.4.449 |
_version_ | 1782177055856656384 |
---|---|
author | Jee, Sun Ha Kim, Hee Jin Lee, Jakyoung |
author_facet | Jee, Sun Ha Kim, Hee Jin Lee, Jakyoung |
author_sort | Jee, Sun Ha |
collection | PubMed |
description | Obesity is a known cause of metabolic syndrome which includes Type II diabetes, hypertension, and dyslipidemia. It is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension. Both obesity and diabetes are emerging topics for researchers to consider as having a possible causal association with cancer since the two factors have been viewed as risk factors for cancer. The present paper introduced the hypothesis of a possible causal relationship between obesity, insulin resistance and cancer and reviews relevant existing studies in this area. More efforts and studies are needed to clarify the mechanisms and the common risk factors which might be incorporated into interventions to prevent cancer and cardiovascular diseases as top causes of death. |
format | Text |
id | pubmed-2815827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Yonsei University College of Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-28158272010-02-04 Obesity, Insulin Resistance and Cancer Risk Jee, Sun Ha Kim, Hee Jin Lee, Jakyoung Yonsei Med J Review Article Obesity is a known cause of metabolic syndrome which includes Type II diabetes, hypertension, and dyslipidemia. It is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension. Both obesity and diabetes are emerging topics for researchers to consider as having a possible causal association with cancer since the two factors have been viewed as risk factors for cancer. The present paper introduced the hypothesis of a possible causal relationship between obesity, insulin resistance and cancer and reviews relevant existing studies in this area. More efforts and studies are needed to clarify the mechanisms and the common risk factors which might be incorporated into interventions to prevent cancer and cardiovascular diseases as top causes of death. Yonsei University College of Medicine 2005-08-31 2005-08-31 /pmc/articles/PMC2815827/ /pubmed/16127767 http://dx.doi.org/10.3349/ymj.2005.46.4.449 Text en Copyright © 2005 The Yonsei University College of Medicine http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Jee, Sun Ha Kim, Hee Jin Lee, Jakyoung Obesity, Insulin Resistance and Cancer Risk |
title | Obesity, Insulin Resistance and Cancer Risk |
title_full | Obesity, Insulin Resistance and Cancer Risk |
title_fullStr | Obesity, Insulin Resistance and Cancer Risk |
title_full_unstemmed | Obesity, Insulin Resistance and Cancer Risk |
title_short | Obesity, Insulin Resistance and Cancer Risk |
title_sort | obesity, insulin resistance and cancer risk |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815827/ https://www.ncbi.nlm.nih.gov/pubmed/16127767 http://dx.doi.org/10.3349/ymj.2005.46.4.449 |
work_keys_str_mv | AT jeesunha obesityinsulinresistanceandcancerrisk AT kimheejin obesityinsulinresistanceandcancerrisk AT leejakyoung obesityinsulinresistanceandcancerrisk |